Advances in brain imaging allowing early detection of the plaques implicated in Alzheimer’s disease have pushed prevention strategies in the fight against dementia.
UAB is a clinical site for the A4 Study of Alzheimer’s disease, recently featured in Newsweek magazine.
The National Multiple Sclerosis Society has named UAB a Center of Comprehensive MS Care, the highest designation in its three-tiered system.
New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. 
A seven-year effort led by a UAB neurologist has established the first guidelines for the use of fMRI in epilepsy surgery.
Alabama now has more EPSCoR Track II grants than any other state following the award of basic science grants meant to stimulate competitive research in regions of the country traditionally less able to compete for such research funds.
UAB researchers release new research findings on effect of CBD oil at national Epilepsy Society Meetings.
Jerzy Szaflarski, M.D., Ph.D., has been selected to be a fellow of the American Epilepsy Society.
UAB neurologists have reported the first case study of a patient with a brain bleed linked to consumption of an energy drink.
The power and promise of personalized medicine: a genetic test can reduce cardiovascular risk for some heart patients.
Page 2 of 9